Igea Pharma

About:

IGEA Pharma focuses on health-tech and med-tech products and devices.

Top Investors: Negma Group

Description:

IGEA Pharma N.V. focuses on health-tech and med-tech products and devices. IGEA commercializes an Alzheimer's prevention set (which includes 'Alz1', an at-home lab test kit to measure non-bound copper in the blood and a natural dietary supplement branded 'Alz1 Tab' designed to reduce blood heavy metals content) and expects to integrate the non-bound copper detection-based pipeline with a diabetes type II prevention set in 2021.

Total Funding Amount:

2M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Hoofddorp, Noord-Holland, The Netherlands

Founded Date:

2018-01-01

Contact Email:

info(AT)igeapharma.nl

Founders:

Vincenzo Moccia

Number of Employees:

1-10

Last Funding Date:

2021-04-15

IPO Status:

Public

Industries: